Cargando…

Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents

Biofilms are bacterial communities that live in association with biotic or abiotic surfaces and enclosed in an extracellular polymeric substance. Their formation on both biotic and abiotic surfaces, including human tissue and medical device surfaces, pose a major threat causing chronic infections. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Amankwah, Stephen, Abdella, Kedir, Kassa, Tesfaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449863/
https://www.ncbi.nlm.nih.gov/pubmed/34548785
http://dx.doi.org/10.2147/NSA.S325594
_version_ 1784569502125522944
author Amankwah, Stephen
Abdella, Kedir
Kassa, Tesfaye
author_facet Amankwah, Stephen
Abdella, Kedir
Kassa, Tesfaye
author_sort Amankwah, Stephen
collection PubMed
description Biofilms are bacterial communities that live in association with biotic or abiotic surfaces and enclosed in an extracellular polymeric substance. Their formation on both biotic and abiotic surfaces, including human tissue and medical device surfaces, pose a major threat causing chronic infections. In addition, current antibiotics and antiseptic agents have shown limited ability to completely remove biofilms. In this review, the authors provide an overview on the formation of bacterial biofilms and its characteristics, burden and evolution with phages. Moreover, the most recent possible use of phages and phage-derived enzymes to combat bacteria in biofilm structures is elucidated. From the emerging results, it can be concluded that despite successful use of phages and phage-derived products in destroying biofilms, they are mostly not adequate to eradicate all bacterial cells. Nevertheless, a combined therapy with the use of phages and/or phage-derived products with other antimicrobial agents including antibiotics, nanoparticles, and antimicrobial peptides may be effective approaches to remove biofilms from medical device surfaces and to treat their associated infections in humans.
format Online
Article
Text
id pubmed-8449863
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84498632021-09-20 Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents Amankwah, Stephen Abdella, Kedir Kassa, Tesfaye Nanotechnol Sci Appl Review Biofilms are bacterial communities that live in association with biotic or abiotic surfaces and enclosed in an extracellular polymeric substance. Their formation on both biotic and abiotic surfaces, including human tissue and medical device surfaces, pose a major threat causing chronic infections. In addition, current antibiotics and antiseptic agents have shown limited ability to completely remove biofilms. In this review, the authors provide an overview on the formation of bacterial biofilms and its characteristics, burden and evolution with phages. Moreover, the most recent possible use of phages and phage-derived enzymes to combat bacteria in biofilm structures is elucidated. From the emerging results, it can be concluded that despite successful use of phages and phage-derived products in destroying biofilms, they are mostly not adequate to eradicate all bacterial cells. Nevertheless, a combined therapy with the use of phages and/or phage-derived products with other antimicrobial agents including antibiotics, nanoparticles, and antimicrobial peptides may be effective approaches to remove biofilms from medical device surfaces and to treat their associated infections in humans. Dove 2021-09-14 /pmc/articles/PMC8449863/ /pubmed/34548785 http://dx.doi.org/10.2147/NSA.S325594 Text en © 2021 Amankwah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Amankwah, Stephen
Abdella, Kedir
Kassa, Tesfaye
Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents
title Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents
title_full Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents
title_fullStr Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents
title_full_unstemmed Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents
title_short Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents
title_sort bacterial biofilm destruction: a focused review on the recent use of phage-based strategies with other antibiofilm agents
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449863/
https://www.ncbi.nlm.nih.gov/pubmed/34548785
http://dx.doi.org/10.2147/NSA.S325594
work_keys_str_mv AT amankwahstephen bacterialbiofilmdestructionafocusedreviewontherecentuseofphagebasedstrategieswithotherantibiofilmagents
AT abdellakedir bacterialbiofilmdestructionafocusedreviewontherecentuseofphagebasedstrategieswithotherantibiofilmagents
AT kassatesfaye bacterialbiofilmdestructionafocusedreviewontherecentuseofphagebasedstrategieswithotherantibiofilmagents